© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
June 24, 2021
Amy R. Dunleavy, PharmD, highlights various drug therapies used for the acute treatment of migraine and provides recommendations for appropriate use.
A panel discussion regarding the underdiagnosis and burden of migraine attacks on patients and the rationale for educating the community about signs and symptoms.
June 23, 2021
A study comparing once-monthly injectable galcanezumab-gnlm with rimegepant has been planned to support the assessment of potential treatments to prevent migraines.
Patients who received non-opioid prescriptions were more likely to report having no pain in the first week after surgery than those who received opioids and both groups reported equal levels of satisfaction.
June 17, 2021
Technicians can help prevent drug diversion, provide care for patients with opioid use disorder.
June 10, 2021
Pharmacists play a role in prevention of opioid overdose by providing information to patients about signs and symptoms.
May 21, 2021
Although the opioid epidemic is a broad societal problem, health systems can play a critical role in the response.
May 17, 2021
Erenumab-aooe (Aimovig, Amgen) is indicated for the preventive treatment of migraine in adults, making it the first approved preventive migraine treatment of its kind.
Programs that provide ongoing support to patients with painful conditions and complex medication regimens may also help them avoid using opioid pain medications or reduce the amount that they use, according to a study published in Rheumatology and Therapy.
May 13, 2021
Finding the right medication or drug combination for individual patients is critical.